U.S. Insurance Stock News

CACI International recently reported quarterly results that surpassed Wall Street expectations, highlighting mid single digit organic growth, expanding operating margins, and a backlog that stretches beyond the current fiscal year. Alongside insider share sales and upcoming conference presentations, investors are paying close attention to CACI’s push toward higher margin, AI-enabled technology solutions and away from lower value staff augmentation work. Next, we’ll examine how this shift...

Investors may be wondering whether Lowe's Companies, at around US$281 a share, still offers value or whether most of the opportunity has already been priced in. The stock has been relatively steady in the short term, with about a 1.2% decline over 7 days and a 1.3% gain over 30 days, while showing returns of 13.9% year to date, 14.4% over 1 year, 47.7% over 3 years and 83.0% over 5 years. Recent coverage around Lowe's has continued to focus on its position as a major US home improvement...

Centrus Energy Corp. reported past fourth-quarter 2025 results with revenue of US$146.2 million and net income of US$17.8 million, alongside full-year revenue of US$448.7 million and net income of US$77.8 million, and issued 2026 revenue guidance of US$425 million to US$475 million. Despite lower quarterly earnings than the prior year, Centrus signaled operational expansion by planning at least 150 net new hires across its Oak Ridge and Piketon facilities in 2026, underscoring management’s...

Labcorp's FY 2025 headline numbers and earnings context Labcorp Holdings (LH) closed out FY 2025 with fourth quarter revenue of US$3,515.8 million and basic EPS of US$2.00, while trailing twelve month EPS came in at US$10.53 on revenue of US$13.95 billion. The company has seen revenue move from US$3,329.4 million in Q4 2024 to US$3,515.8 million in Q4 2025, with quarterly basic EPS shifting from US$1.72 to US$2.00 over the same period. This set up a year where reported earnings grew 17.5% and...

Wingstop earnings in focus Wingstop (WING) heads into its earnings report this Wednesday with investor attention centered on last quarter’s 5% revenue miss versus expectations and the relatively steady analyst estimates maintained over the past month. See our latest analysis for Wingstop. Wingstop’s share price has been volatile recently, with a 13.6% 1 day share price return following a softer 30 day share price return of an 8.9% decline. Its 5 year total shareholder return of 95.4% points...

Synaptics (SYNA) moved into focus after quarterly results and fresh guidance highlighted both its role in AI related human interface chips and its ongoing losses, giving investors a mixed but closely watched update. See our latest analysis for Synaptics. The recent 1 day share price return of a 6% decline, alongside a 6% decline over 30 days, contrasts with a 42% 90 day share price return and a 16% 1 year total shareholder return. This suggests strong momentum that has cooled as investors...

Patient Capital Management and Ranger Investment Management have taken sizable new positions in Chime Financial (NasdaqGS:CHYM). These institutional moves follow strong year over year revenue growth and an expanding active member base. Chime continues to report operating losses tied to higher technology and development expenses. Chime Financial focuses on digital banking services, offering app based accounts and tools that aim to simplify everyday money management. The wider fintech sector...

Black Swift Group, LLC has fully exited its position in MercadoLibre (NasdaqGS:MELI). The divestment comes as investors focus on rising competition in e commerce and fintech across MercadoLibre's core Latin American markets. Concerns about bad loan provisions in the company’s credit portfolio are adding to the debate around risk and profitability. MercadoLibre operates a large e commerce marketplace alongside digital payments and credit services across Latin America, so shifts in...

RB Global (RBA) just released full year 2025 results, giving investors fresh numbers to assess the commercial asset marketplace. Revenue came in at US$4,590.7m and net income at US$428.4m, alongside modest EPS gains. See our latest analysis for RB Global. The earnings release appears to have been the main catalyst for the recent 2.04% 1 day share price return. However, the stock still shows a 12.64% 7 day share price decline, while its 1 year total shareholder return of 9.01% and 5 year total...

Southern Michigan Bancorp (SOMC) has just closed out FY 2025 with fourth quarter revenue of US$13.7 million, basic EPS of US$0.63 and trailing twelve month EPS of US$2.65, alongside year over year earnings growth of 17.4%. Over recent quarters the company has seen revenue move from US$12.6 million and basic EPS of about US$0.57 in Q4 2024 to between US$13.1 million and US$13.9 million with EPS ranging from US$0.63 to US$0.70 through FY 2025. This has fed into trailing twelve month revenue of...

If you are wondering whether Arbor Realty Trust's current share price reflects its real worth, this breakdown will help you see how the market price stacks up against several valuation methods. The stock last closed at US$7.33, with returns of a 6.7% decline over 7 days, an 11.4% decline over 30 days, a 7.8% decline year to date and a 39.9% decline over 1 year, along with a 31.0% decline over 3 years and a 23.5% decline over 5 years, which may have changed how investors view both its risk...

If you are wondering whether JinkoSolar Holding is offering good value at its recent US$26.47 share price, you are not alone in asking if the current market tag really reflects the business behind the ticker. The stock has been volatile recently, with a 10.0% decline over the last 7 days and a 10.3% decline over the last 30 days, even though the 1 year return sits at 24.1% while the 3 year and 5 year returns are 36.7% and 37.0% declines respectively. Recent coverage around the solar and...

Axogen (AXGN) has drawn fresh attention after recent data flagged the stock as fitting the Minervini Trend Template, alongside management’s planned appearances at several high profile investor conferences. See our latest analysis for Axogen. Those Minervini signals and the upcoming conference appearances are playing out against a backdrop of firm momentum, with a 30 day share price return of 11.67% and a 1 year total shareholder return of 92.98% that together suggest buyers have been...

What Coty’s recent share performance signals for investors Coty (COTY) has drawn fresh attention after a period where the share price has fallen about 16% over the past month and roughly 21% in the past 3 months. This has prompted investors to reassess expectations. See our latest analysis for Coty. Stepping back from the recent pullback, Coty’s share price return year to date is about 18% lower. The 1 year total shareholder return of roughly 55% decline signals that longer term holders have...

Ford Motor (F) is moving further into hybrids and low cost EVs while exploring joint ventures with Chinese automakers, a backdrop that gives fresh context to recent moves in Ford stock. See our latest analysis for Ford Motor. Those product plans, the recent 10 K outlining the Ford+ plan, and fresh talks about joint ventures with Chinese automakers come against a backdrop of a 59.91% 1 year total shareholder return and a 9.53% 90 day share price return, which suggests that momentum has been...

Inspire Medical Systems (INSP) has drawn fresh attention after cutting its 2026 outlook and highlighting reimbursement uncertainty tied to a new CPT code, alongside analyst rating changes and emerging legal scrutiny around prior disclosures. See our latest analysis for Inspire Medical Systems. The recent cut to 2026 guidance and reimbursement uncertainty has coincided with a sharp pullback, with a 30 day share price return of a 34.52% decline and a 1 year total shareholder return of a 66.46%...

CRISPR Therapeutics reported rapid commercial expansion of Casgevy, its FDA approved gene editing treatment for sickle cell disease, with patient initiations nearly tripling year over year. Coverage and reimbursement for Casgevy now extend across much of the US, Europe, and the Middle East, reaching a majority of eligible patients. The company is progressing in vivo gene editing programs targeting cardiovascular and autoimmune diseases, as well as oncology, adding momentum beyond recent...

Warrior Met Coal (HCC) is back in the spotlight after reporting Q4 2025 results that combined record steelmaking coal production, the early ramp of its Blue Creek mine, and higher 2026 volume guidance. See our latest analysis for Warrior Met Coal. The recent Q4 2025 production records, early Blue Creek ramp up and updated 2026 guidance have arrived after a 90 day share price return of 12.11%, while the 1 year total shareholder return of 69.46% and 5 year total shareholder return of 272.55%...

Ceragon Networks (NasdaqGS:CRNT) has wrapped up FY 2025 with fourth quarter revenue of US$82.3 million and basic EPS of about US$0.001, alongside net income of roughly US$0.1 million. This keeps the full year on a trailing 12 month loss of US$2.1 million, or EPS of about US$0.02. The company has seen quarterly revenue range from US$88.7 million in Q1 2025 to US$82.3 million in Q4 2025, while basic EPS moved from a loss of about US$0.01 in the first half to small positive readings of roughly...

New York Times Advertising and Magnite announced an expanded partnership to make Magnite DV+ the preferred platform for private marketplace deals. The agreement focuses on New York Times mobile in app ad supply, connecting advertisers with the publisher's mobile audience. The news relates to The New York Times Company (NYSE:NYT) and Magnite's role as an advertising technology partner. For you as an investor looking at NYSE:NYT, this move sits at the intersection of digital media and ad...

Krystal Biotech (KRYS) closed FY 2025 with Q4 revenue of US$107.1 million and basic EPS of US$1.77, rounding out a year where trailing twelve month revenue reached US$389.1 million and EPS came in at US$7.08, alongside reported earnings growth of 129.7% year over year. Over the past six quarters in the dataset, revenue has moved from US$83.8 million in Q3 2024 to US$107.1 million in Q4 2025. Quarterly basic EPS tracked from US$0.95 to US$2.74 and then US$1.77, setting the backdrop for a...

Zoetis (ZTS) is back in focus after reporting quarterly and full year 2025 results that came in ahead of analyst expectations, along with 2026 guidance and fresh institutional buying interest. See our latest analysis for Zoetis. Despite the strong 2025 earnings update, recent trading has been subdued. A 7.24% 90 day share price return contrasts with a 1 year total shareholder return decline of 18.59%, suggesting longer term sentiment has been weaker even as shorter term momentum has picked...

Dollar Tree (NasdaqGS:DLTR) is expanding its price range up to $10, moving away from its traditional single price model. The company is placing more emphasis on attracting wealthier shoppers, alongside its existing budget focused customer base. This shift has led to visible customer backlash and questions about how the brand will serve lower income consumers. For you as an investor, this is a meaningful change in how Dollar Tree, long known for a simple fixed price format, presents itself...

Franklin Electric (FELE) just closed out FY 2025 with Q4 revenue of US$506.9 million and basic EPS of US$0.87, alongside trailing twelve month revenue of about US$2.1 billion and EPS of US$3.25. Over the past few quarters, the company has seen revenue range from US$455.2 million to US$587.4 million and quarterly EPS move between US$0.37 and US$1.32. This gives investors a clear look at how the top line and EPS have tracked into the latest print. At the same time, a softer net margin backdrop...